Narasimhan Ragavan

Narasimhan Ragavan

Auto-generated profile, based on publicly available information

Narasimhan Ragavan

Urology, Apollo Hospitals, Chennai, IND

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Urology Research and Practice
Verified
Journal Article
Closed access
NRNarasimhan Ragavan
Narasimhan Ragavan
SBSandeep Bafna
Sandeep Bafna
MTMathisekaran Thangarasu
Mathisekaran Thangarasu
SPSanjay Prakash
Sanjay Prakash
RPRajesh Paul
Rajesh Paul
SRSrivathsan Ramani
Srivathsan Ramani
Objective: The delivery of surgical services has undergone a shift in the past decade with increasing numbers of surgeries being performed in the daycare setting. Implementing a minimally invasive surgical approach with a robot with an enhanced recovery protocol permits robot-assisted laparoscopic surgeries (RALS) to be performed as a day-case (DC) procedure. This study aimed to assess the feasibility and safety of DC surgery according to our experience. Material and methods: In this prospective observational study, 43 patients underwent DC RALS performed by a single surgeon over 18 months [simple nephrectomy (n=7), radical nephrectomy (n=15), radical nephrectomy with para-aortic lymphadenectomy (n=5), and adrenalectomy (n=5)]. In addition, reconstructive urological procedures that included pyeloplasty (n=9), ureteroureterostomy (n=1), and bladder diverticulectomy with ureteric re-implantation (n=1) were performed as DC surgeries during this study period. RALS was performed in the standard way with an enhanced recovery pathway of care for DC. We collected data regarding the demographic information, medical comorbidities, preoperative outcomes, intraoperative outcomes, complications, length of stay, and readmission rates. The data were analyzed and evaluated. Results: All the patients (100%) were successfully discharged on the same day with no major complications (Clavien–Dindo grade>I). The readmission rates were 0%. Conclusion: DC RALS are safe and feasible with an enhanced recovery protocol. With adequate protocols in place, these surgeries might prove to be better than the available minimally invasive techniques and can become the standard of care in the future. Cite this article as: Ragavan N, Bafna S, Thangarasu M, Prakash S, Paul R, Chirravur P. Day-case robot-assisted laparoscopic surgery: Feasibility and safety. Turk J Urol 2021; 47(1): 30-4.

20 August 2020 in Cureus
Verified
Journal Article
Open access
PDF file
NRNarasimhan Ragavan
Narasimhan Ragavan
NSNivash Selvaraj
Nivash Selvaraj
DRDeepak Raghavan
Deepak Raghavan
RKRamesh Kamalakannan
Ramesh Kamalakannan
TGThirumalai Ganesan Govindaswamy
Thirumalai Ganesan Govindaswamy
NJNitesh Jain
Nitesh Jain
Objective: Open adrenalectomy (OA) is considered to be the standard care for large adrenal tumors. Minimally invasive surgery (MIS) using laparoscopic technique is considered for many patients in the modern era. Robot assisted laparoscopic adrenalectomy (RALA) can be an extremely useful tool which will negate the disadvantage of laparoscopic method. The aim of the present study is to determine whether adrenal tumor size and laterality have an impact on patients undergoing RALA with respect to perioperative and postoperative outcomes. Methods: During the study period, 38 patients who underwent RALA in a tertiary care center were considered for retrospectively analysis. The study populations were subdivided into distinctive groups based on the tumor size (= 5 cm, = 8cm), and side (right and left side). For all the subgroups, perioperative and postoperative outcomes were analyzed. Perioperative and postoperative outcomes were assessed between patient groups, group a) = 5 cm tumor, group b) = 8 cm, and group c) laterality (right vs left). Results: None of the patients showed any differences. In the current study, the conversion rate, readmission, and mortality were not observed. No major complications were noted. Conclusion: RALA appears to be an extremely viable alternative to MIS using laparoscopic technique. The operative time, console time, blood loss, complication rates, and stay were extremely minimal irrespective of the size or laterality of the adrenal tumor.

4 July 2012 in International Journal of Urology
Verified
Journal Article
Closed access
PDF file
MDMinh Do
Minh Do
NRNarasimhan Ragavan
Narasimhan Ragavan
ADAnja Dietel
Anja Dietel
ELEvangelos Liatsikos
Evangelos Liatsikos
CAChris Anderson
Chris Anderson
JSJens-Uwe Stolzenburg
Jens-Uwe Stolzenburg

5 December 2024 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
DSDeerush Kannan Sakthivel
Deerush Kannan Sakthivel
ARAmrithavarshini Ragavan
Amrithavarshini Ragavan
SBSandeep Bafna
Sandeep Bafna
NRNarasimhan Ragavan
Narasimhan Ragavan
MRMeera Ragavan
Meera Ragavan

12 July 2016 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
NRNarasimhan Ragavan
Narasimhan Ragavan
MRMalarvizhi Ramesh
Malarvizhi Ramesh
NKNarayanan Kandasamy
Narayanan Kandasamy
YRY. Vijayachandra Reddy
Y. Vijayachandra Reddy

13 October 2021 in Cureus
Verified
Journal Article
Open access
NSNivash Selvaraj
Nivash Selvaraj
KDKunal Dholakia
Kunal Dholakia
NRNarasimhan Ragavan
Narasimhan Ragavan
Tobacco use, especially cigarette smoking, is a well-documented risk factor for cancer; however, its specific effect on bladder cancer has not been clearly defined. This study aimed to determine the association between tobacco use and bladder cancer in a South Asian population. We conducted a retrospective review of the medical records of 64 patients diagnosed with bladder tumors from February 2018 to March 2020. Patients included in the study were surveyed via a questionnaire regarding tobacco use. All patients received transurethral resection of the bladder tumor, and we analyzed histopathological and clinical outcomes. Our study population’s median age was 57 years, and the study included twice as many male patients as female patients. Most patients (n=45; 70%) reported not using tobacco products, and 19 patients (30%) reported tobacco use. Thirty-five of 45 nontobacco users (78%) had high-grade cancer, and 10 (22%) had low-grade cancer. Among the tobacco users, 10 (52%) had high-grade cancer, and nine (48%) had low-grade cancer. According to our findings, a substantial cohort of bladder cancer patients is not tobacco users, and high-grade bladder cancer was more common to people who are not tobacco users. Other environmental factors play a key role in developing bladder cancer in our South Asian study population. Prevention efforts should focus on reducing bladder cancer risk factors.